IOMED INC·4

Aug 13, 1:52 PM ET

IOMED INC 4

4 · IOMED INC · Filed Aug 13, 2007

Insider Transaction Report

Form 4
Period: 2007-08-09
FARA JOHN W
Director
Transactions
  • Disposition to Issuer

    stock options

    2007-08-09$8.88/sh1,041$9,2440 total
    Exercise: $8.88From: 2007-08-09Exp: 2007-08-09common stock (10,000 underlying)
  • Disposition to Issuer

    Stock option

    2007-08-09$1.72/sh15,000$25,8000 total
    Exercise: $1.72From: 2007-08-09Exp: 2007-08-09common stock (15,000 underlying)
  • Disposition to Issuer

    Stock Option

    2007-08-09$2.43/sh15,000$36,4500 total
    Exercise: $2.43From: 2007-08-09Exp: 2007-08-09common stock (15,000 underlying)
  • Disposition to Issuer

    stock options

    2007-08-09$2.20/sh15,000$33,0000 total
    Exercise: $2.20From: 2007-08-09Exp: 2007-08-09common stock (15,000 underlying)
  • Disposition to Issuer

    Stock Options

    2007-08-09$6.50/sh15,000$97,5000 total
    Exercise: $6.50From: 2007-08-09Exp: 2007-08-09common stock (15,000 underlying)
  • Disposition to Issuer

    stock options

    2007-08-09$3.88/sh10,000$38,7500 total
    Exercise: $3.88From: 2007-08-09Exp: 2007-08-09common stock (10,000 underlying)
Footnotes (2)
  • [F1]This option was cancelled pursuant to the merger between issuer, ReAble Therapeutics, Inc. and Spartan Acquisition Corp. A cash payment represetning the difference between the exercise price of the option and the market value of the underlying Iomed common stock on this effective date ofthe merger ($2.75 per share) was made.
  • [F2]This option was cancelled pursuant to the merger between issuer, ReAble Therapeutics, inc. and Spartan Acquisition Corp. There was no cash payment made because the option price was below the market value of the underlying Iomed common stcok on the effective date of the merger.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT